F
$ Value
$39K
Shares
1,642
Price
$24
Filed
Oct 28
Insider
Name
Gao Hanlin
Title
Chief Scientific Officer
CIK
0001684532
Roles
Officer
Transaction Details
Transaction Date
2025-10-26
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
955,443
Footnotes
The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units assumed pursuant to the Agreement and Plan of Merger, dated as of November 7, 2022 by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. These awards were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on November 9, 2022.
Filing Info
Gao Hanlin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-26 | FLGT | F | $37K |
| 2025-12-02 | FLGT | ▼ | $30K |
| 2025-11-28 | FLGT | ▼ | $28K |
| 2025-11-24 | FLGT | ▼ | $16K |
| 2025-10-26 | FLGT | F | $39K |
| 2025-09-03 | FLGT | ▼ | $23K |
| 2025-08-27 | FLGT | ▼ | $20K |
| 2025-08-25 | FLGT | ▼ | $12K |
| 2025-07-26 | FLGT | F | $30K |
| 2025-06-02 | FLGT | ▼ | $15K |
Other Insiders at FLGT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Kim Paul
CFO and Treasurer
|
— | — | 2026-01-26 |
|
Hsieh Ming
Chief Executive Officer
|
— | — | 2026-03-09 |
|
Gao Hanlin
Chief Scientific Officer
|
— | — | 2026-01-26 |
|
Xie Jian
President and COO
|
— | — | 2026-01-26 |